152 related articles for article (PubMed ID: 24486392)
1. Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats.
She M; Hu X; Su Z; Zhang C; Yang S; Ding L; Laudon M; Yin W
Eur J Pharmacol; 2014 Mar; 727():60-5. PubMed ID: 24486392
[TBL] [Abstract][Full Text] [Related]
2. NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats.
She M; Deng X; Guo Z; Laudon M; Hu Z; Liao D; Hu X; Luo Y; Shen Q; Su Z; Yin W
Pharmacol Res; 2009 Apr; 59(4):248-53. PubMed ID: 19429466
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Receptor Agonist Piromelatine Ameliorates Impaired Glucose Metabolism in Chronically Stressed Rats Fed a High-Fat Diet.
Zhou J; Wang D; Luo X; Jia X; Li M; Laudon M; Zhang R; Jia Z
J Pharmacol Exp Ther; 2018 Jan; 364(1):55-69. PubMed ID: 29025979
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure reducing effects of piromelatine and melatonin in spontaneously hypertensive rats.
Huang L; Zhang C; Hou Y; Laudon M; She M; Yang S; Ding L; Wang H; Wang Z; He P; Yin W
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2449-56. PubMed ID: 24089222
[TBL] [Abstract][Full Text] [Related]
5. Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: role of ATGL and HSL.
Wang PP; She MH; He PP; Chen WJ; Laudon M; Xu XX; Yin WD
Biochimie; 2013 Aug; 95(8):1650-4. PubMed ID: 23707538
[TBL] [Abstract][Full Text] [Related]
6. Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in rats.
Zhou J; Zhang J; Luo X; Li M; Yue Y; Laudon M; Jia Z; Zhang R
Eur J Pharmacol; 2017 Oct; 812():225-233. PubMed ID: 28687198
[TBL] [Abstract][Full Text] [Related]
7. Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain.
Liu YY; Yin D; Chen L; Qu WM; Chen CR; Laudon M; Cheng NN; Urade Y; Huang ZL
Psychopharmacology (Berl); 2014 Oct; 231(20):3973-85. PubMed ID: 24700387
[TBL] [Abstract][Full Text] [Related]
8. Neu-P11 - a novel melatonin receptor agonist, could improve the features of type-2 diabetes mellitus in rats.
Li X; He J; Li X; Li Y; Zhou Y; Cai S
Endokrynol Pol; 2021; 72(6):634-642. PubMed ID: 34647606
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemic and hypolipidemic effects of Coriandrum sativum L. in Meriones shawi rats.
Aissaoui A; Zizi S; Israili ZH; Lyoussi B
J Ethnopharmacol; 2011 Sep; 137(1):652-61. PubMed ID: 21718774
[TBL] [Abstract][Full Text] [Related]
10. A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease.
He P; Ouyang X; Zhou S; Yin W; Tang C; Laudon M; Tian S
Horm Behav; 2013 Jun; 64(1):1-7. PubMed ID: 23651610
[TBL] [Abstract][Full Text] [Related]
11. Metabolic consequences of chronic sleep restriction in rats: changes in body weight regulation and energy expenditure.
Barf RP; Van Dijk G; Scheurink AJ; Hoffmann K; Novati A; Hulshof HJ; Fuchs E; Meerlo P
Physiol Behav; 2012 Oct; 107(3):322-8. PubMed ID: 22995976
[TBL] [Abstract][Full Text] [Related]
12. Melatonin improves metabolic syndrome induced by high fructose intake in rats.
Kitagawa A; Ohta Y; Ohashi K
J Pineal Res; 2012 May; 52(4):403-13. PubMed ID: 22220562
[TBL] [Abstract][Full Text] [Related]
13. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats.
Ríos-Lugo MJ; Cano P; Jiménez-Ortega V; Fernández-Mateos MP; Scacchi PA; Cardinali DP; Esquifino AI
J Pineal Res; 2010 Nov; 49(4):342-8. PubMed ID: 20663045
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models.
Buendia I; Gómez-Rangel V; González-Lafuente L; Parada E; León R; Gameiro I; Michalska P; Laudon M; Egea J; López MG
Neuropharmacology; 2015 Dec; 99():187-95. PubMed ID: 26188145
[TBL] [Abstract][Full Text] [Related]
15. Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats.
Fu W; Xie H; Laudon M; Zhou S; Tian S; You Y
Psychopharmacology (Berl); 2016 Jun; 233(12):2229-39. PubMed ID: 27007604
[TBL] [Abstract][Full Text] [Related]
16. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
17. Melatonin ameliorates cognitive impairment induced by sleep deprivation in rats: role of oxidative stress, BDNF and CaMKII.
Zhang L; Zhang HQ; Liang XY; Zhang HF; Zhang T; Liu FE
Behav Brain Res; 2013 Nov; 256():72-81. PubMed ID: 23933144
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model.
Sil R; Ray D; Chakraborti AS
Indian J Exp Biol; 2013 Feb; 51(2):129-38. PubMed ID: 23923606
[TBL] [Abstract][Full Text] [Related]
19. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
Qi Z; Xue J; Zhang Y; Wang H; Xie M
Planta Med; 2011 Feb; 77(3):231-5. PubMed ID: 20717873
[TBL] [Abstract][Full Text] [Related]
20. Diet-induced central obesity and insulin resistance in rabbits.
Zhao S; Chu Y; Zhang C; Lin Y; Xu K; Yang P; Fan J; Liu E
J Anim Physiol Anim Nutr (Berl); 2008 Feb; 92(1):105-11. PubMed ID: 18184386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]